(Q58329628)

4

0 references

author name string

Lisa Arnetz

1

0 references

Mozhgan Dorkhan

2

0 references

Michael Alvarsson

Hypothalamic arousal, insulin resistance and Type 2 diabetes mellitus

3

0 references

publication date

7 February 2013

0 references

published in

Acta Diabetologica

0 references

volume

51

0 references

issue

2

0 references

page(s)

185-192

0 references

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0457-Y

Sex differences in coronary heart disease. Why are women so superior? The 1995 Ancel Keys Lecture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0457-Y

The role of insulin-like growth factor-I and its binding proteins in glucose homeostasis and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0457-Y

Growth hormone and protein metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0457-Y

IGF-dependent and IGF-independent actions of IGF-binding protein-1 and -2: implications for metabolic homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0457-Y

Insulin-like growth factor binding protein 1 as a novel specific marker of hepatic insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0457-Y

Insulin regulates the 35 kDa IGF binding protein in patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0457-Y

Close relation of fasting insulin-like growth factor binding protein-1 (IGFBP-1) with glucose tolerance and cardiovascular risk in two populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0457-Y

New mechanisms of glucocorticoid-induced insulin resistance: make no bones about it.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0457-Y

Effects of Peroxisome Proliferator-Activated Receptor-α and -γ Agonists on 11β-Hydroxysteroid Dehydrogenase Type 1 in Subcutaneous Adipose Tissue in Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0457-Y

Functional PPAR-gamma receptor is a novel therapeutic target for ACTH-secreting pituitary adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0457-Y

Glycaemic and nonglycaemic effects of pioglitazone in triple oral therapy of patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0457-Y

Circulating IGF binding protein-1 is inversely associated with leptin in non-obese men and obese postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0457-Y

Effects on glucose tolerance, insulin secretion, insulin-like growth factor 1 and its binding protein, IGFBP-1, in a randomized controlled diet and exercise study in healthy, middle-aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0457-Y

Plasma concentration of IGF-I is independently associated with insulin sensitivity in subjects with different degrees of glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0457-Y

A randomized placebo-controlled study on the effects of pioglitazone on cortisol metabolism in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0457-Y

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0457-Y

Molecular mechanism of insulin resistance in type 2 diabetes mellitus: role of the insulin receptor variant forms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0457-Y

Expression of insulin/IGF-I hybrid receptors is increased in skeletal muscle of patients with chronic primary hyperinsulinemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0457-Y

Leptin and adiponectin: distribution and associations with cardiovascular risk factors in men and women of the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0457-Y

Adiponectin expression in humans is dependent on differentiation of adipocytes and down-regulated by humoral serum components of high molecular weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0457-Y

Review: Peroxisome proliferator-activated receptor gamma and adipose tissue--understanding obesity-related changes in regulation of lipid and glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0457-Y

Sex-specific differences in cortisol production rates in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0457-Y

Fibroblast growth factor-21 regulates PPARγ activity and the antidiabetic actions of thiazolidinediones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0457-Y

Effects of chronic administration of PPAR-gamma ligand rosiglitazone in Cushing's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0457-Y

Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0457-Y

Neurochemical regulation of sleep

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0457-Y

Recombinant human IGF-I does not modify the ACTH and cortisol responses to hCRH and hexarelin, a peptidyl GH secretagogue, in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0457-Y

Subclinical Cushing's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0457-Y

Thiazolidinedione use and bone loss in older diabetic adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0457-Y

Prevention and treatment strategies for glucocorticoid-induced osteoporotic fractures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0457-Y

Identification of multiple glucocorticoid receptor binding sites in the rat osteocalcin gene promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-013-0457-Y